LabCorp Earnings: Solid Start to 2026 With Few Surprises as Medical Utilization Remains Robust
LabCorp's first-quarter results included top-line and EBIT growth of 6% and 17%, respectively. Operating margin expanded roughly 110 basis points compared with the prior-year period. Management raised its outlook modestly.